ABSTRACT Summary: POSBIOTM-NER is a trainable biomedical named-entity recognition system. POSBIOTM-NER can be automatically trained and adapted to new datasets without performance degradation, using CRF (conditional random field) machine learning techniques and automatic linguistic feature analysis. Currently, we have trained our system on three different datasets.
INTRODUCTION
There exists a large amount of biomedical literature and the volume continues to grow exponentially. These publications embody a store of knowledge and information of interactions and relations among biological entities, which is very important for the understanding of biological processes. To perform interaction extraction from literature, the most elementary and core problem is the identification of material names concerned, which is known as named-entity recognition (NER) in natural language processing community.
Diversified named-entities are involved in different sorts of interactions in the specific domain. There is an increasing need for tools that can be adapted to multifarious biomedical domain to recognize the requisite entities.
Recent researchers mainly used machine learning models for the biomedical named-entity task. GENIA corpus (Kim et al., 2003) and BioCreative corpus (Blaschke et al., 2004, http://www.pdg. cnb.uam .es/BioLINK/workshop BioCreative 04/handout/) are freely available as training materials. The system performance of GNEIA corpus varies from 63.0 to 72.2, according to the report on Bio-Entity Recognition task at BioNLP/NLPBA 2004 (Kim et al., 2004) . The performances of systems at BioCreative vary from 50.1 to 83.2. In the case of closed corpus, the best performance is 82.2 (Blaschke et al., 2004) .
The named-entity recognition problem is regarded as a classification problem, marking up input sequences with named-entity category labels. The input sequences are represented as sets of features. The models based on hidden Markov model (HMM) and maximum entropy are generalizable and adaptable to new classes of * To whom correspondence should be addressed.
words. HMM is a standard tool in the NER task. Collier et al. (2000) used an HMM to extract the names of genes and gene products. Zhou et al. (2004) proposed a rich set of features, integrated via HMM with back-off modeling. However, HMM suffers from the data sparseness problem and is not practical to represent multiple interacting features or long-range dependencies of the observations. Also it has a very strict independent assumption on the observation. An alternative is a conditional model, which allows arbitrary non-independent features on the observation sequence. Dingare et al. (2004) presents a maximum entropy Markov model (MEMM)-based system incorporating diverse set of features for identifying genes and proteins in biomedical abstracts for the BioCreative task1A. Still, MEMM is subject to the label bias 1 problem (Lafferty et al., 2001 ). Our POSBIOTM-NER system is designed as a trainable Biomedical NER system. It can be adapted to new datasets without any further human effort. In our system, we adopt the Conditional Random Field (CRF) model (Lafferty et al., 2001) for the biomedical named-entity recognition task. The CRF model has all the advantages of conditional models and can handle the label bias problem. The CRF model is globally conditioned on the input sequences, resulting in a global optimal model. Various linguistic features are used to achieve better performance, such as part-of-speech 2 (POS) tag and base noun phrase 3 (NP) tag. Our system has been validated by three different datasets, including GENIA corpus and BioCreative corpus. For all the datasets, our system gives competitive performances. Our system also provides a client tool to access to our system and make use of modules. Please visit our system website for details.
SYSTEM DESCRIPTION
POSBIOTM-NER is a trainable biomedical named-entity recognition system. An overview of the system architecture is shown in Figure 1 . The system is composed of named-entity (NE) detection Module and NER model training module. The training module can be adapted to a new training data and build a new NER model. The produced NER models are employed in the detection module to perform the named-entity recognition task. Currently, we provide three target-specific NER models: GENIA-NER model, GENE-NER model and GPCR-NER model. One easy and convenient way to make use of our system to perform the named-entity task is to utilize 1 Label bias: bias toward states with fewer outgoing transitions.
2 Part-of-speech: the part of speech is the term used to describe how a particular word is used. For example, noun, verb, etc. 3 NP: a noun phrase comprises a noun and any number of associated modifiers. the client tool. Client tool is a part of our currently developing POS-BIOTM workbench. The workbench provides a friendly graphical user interface and a set of tools which support collecting, managing, creating, annotating and exploiting biomedical text resources. The client tool and the whole binary code are freely available at http://isoft.postech.ac.kr/Research/BioNER/POSBIOTM/NER/ main.html. The client tool supports access to PubMed by using our incremental PubMed search engine. Users can maintain their own search keyword lists with specific search strategies, such as searching only in a predefined subset of Pubmed citations that meet the interest of users. The users can select one of the three NER models and transfer the chosen texts to the system, and then the detection module will perform the named-entity recognition task.
Before the selected texts are passed to the NE detection module, they are split into sentences and tokenized at the preprocessing step. Then each token in the sentences will be assigned with a POS tag and an NP tag. For each token, various kinds of features are extracted. These features are used to fully describe the local contexts of this token. The NER results are stored in the XML form. One example of the output is as follows:
The <protein>sphingosine-1-phosphate receptor </protein> <protein>EDG-1 </protein> is essential for <protein> platelet-derived growth factor </protein> -induced <cellular process>cell motility </cellular process>.
Most of the current biomedical NER systems are designed to recognize only one given set of named entities, and moreover, handcrafted rules are used to enhance the performance. So, they can hardly be adapted to new datasets. Our system is a fully automatic trainable system. It can be adapted to different datasets without any modification. The only thing a user should provide is a training corpus. Feature sets, which are used to describe the distinctive characteristics of the tokens, as well as other useful information, will be obtained directly from the training corpus by using linguistic processing. The training corpus has to be provided in IOB notation. The IOB notation is used where named entities are not nested and therefore, do not overlap. Words outside of named entities are tagged with 'O', while the first word in a named entity is tagged with B-[entity class], and further named-entity words receive tag I-[entity class] for inside.
Our POSBIOTM-NER uses the following basic linguistic features:
• Surface word-word itself and word combination. Only in the case that the previous/current/next words are in the surface word dictionary.
• Word feature-orthographical features of the previous/current/ next words.
• Prefix/suffix-prefixes/suffixes which are contained in the current word among the entries in the prefix/suffix dictionary.
• POS tag-part-of-speech tag of the previous/current/next words.
• NP tag-base noun phrase tag of the previous/current/next words.
DIFFERENT NER MODELS
The GENIA-NER model uses GENIA corpus version 3.02 as a training corpus, which contains five target named-entity categories: protein, cell_line, cell_type, DNA and RNA. The GENIA corpus consists of 2000 MEDLINE abstracts, mainly concerning transcription factors in human blood cells and 404 abstracts are used as a test data.
The GENE-NER model uses BioCreative corpus. The aim of the GENE-NER model is the identification of terms in biomedical research articles, which are gene and/or protein names. The training corpus consists of 7.5 k sentences, selected from MEDLINE
